Overview of Digestina
Digestina is a medication containing the International Nonproprietary Name (INN) active ingredient Bromopride, an oral, synthetic compound primarily used for its effects on the digestive system. Its pharmacological classification identifies it as a prokinetic agent and an anti-emetic. This drug is a single-ingredient product designed to influence gut movement and suppress signals that cause the feeling of sickness, a function utilized in managing symptoms associated with various gastrointestinal disturbances.
Quick Facts
| Property | Description |
|---|---|
| Active Ingredient | Bromopride |
| Form | Oral tablet, Oral solution (liquid) |
| Pharmacological Class | Prokinetic agent, D2 Dopamine Antagonist |
| Common Use | Restoring coordinated gastrointestinal motility |
| Origin | Synthetic (Substituted benzamide) |
What Type of Medicine is Digestina (Bromopride)?
The active substance Bromopride is formally classified under the Anatomical Therapeutic Chemical (ATC) code A03FA04 (Propulsives), identifying its role in functional gastrointestinal disorders. Bromopride is chemically a derivative of substituted benzamide, a differentiating factor that places it in the same chemical family as the related prokinetic agent metoclopramide. It executes its function primarily as a dopamine D2 receptor antagonist, which means it blocks the action of dopamine in specific areas of the gut and the central nervous system. This multi-site mechanism relates to its use in preventing specific types of nausea.
Composition and Available Forms
Digestina is a single-ingredient formulation containing only the active pharmaceutical ingredient, Bromopride. This medication is specifically designed for oral administration, and is typically supplied in two common dosage forms: the solid oral tablet and the liquid oral solution (sometimes marketed as drops). The availability of an oral solution, which often employs an aqueous vehicle as its primary base, is a key feature that facilitates administration, particularly in patient groups requiring ease of swallowing.
What is Digestina’s General Purpose?
The general purpose of this medication is to normalize and improve coordinated movement within the upper digestive tract and to provide effective control over nausea and vomiting. As a prokinetic agent, it stimulates the muscles of the stomach and small intestine, thereby accelerating gastric emptying and reducing the discomfort associated with delayed food transit. The anti-emetic action is achieved centrally by blocking specific signals in the chemoreceptor trigger zone (CTZ), reducing the propensity for sickness and vomiting. This dual therapeutic effect is intended for scenarios where poor gut motility causes both discomfort and nausea.
